Bfsg, LLC Dexcom Inc Transaction History

Bfsg, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	SELL	$67.99 - $132.89 $129,248 - $252,623	-1,901 Closed	0 $0
Q1 2022 May 04, 2022	SELL	$94.08 - $130.2 $9,690 - $13,410	-103 Reduced 5.14%	1,901 $973,000
Q4 2021 Jan 24, 2022	BUY	$129.87 - $162.82 $4,155 - $5,210	32 Added 1.62%	2,004 $1.08 Million
Q3 2021 Nov 03, 2021	BUY	$106.71 - $143.18 $210,432 - $282,350	1,972 New	1,972 $1.08 Million
Q4 2018 Jan 24, 2019	SELL	$26.99 - $37.37 $86,071 - $119,172	-3,189 Closed	0 $0
Q3 2018 Oct 18, 2018	BUY	$23.35 - $36.72 $74,463 - $117,100	3,189 New	3,189 $456,000

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Bfsg, LLC, based on Form 13F filings with the SEC.

Stay updated on Bfsg, LLC with notifications on news.